PolyU scholars win TechConnect Innovation Awards for seventh consecutive year
World-class research centre with NVIDIA and more to drive innovation in culture, art-tech, and interactive media
Significant research funding secured to advance sustainable development and mental healthcare in Hong Kong
PolyU scholars have won two prestigious TechConnect World Innovation Conference and Expo 2023 (TechConnect) Global Innovation Awards, marking the University’s seventh consecutive year of winning these esteemed accolades. With these two innovations in the areas of “energy, efficiency and environmental” and “medical devices and materials”, PolyU was the only higher education institution in Hong Kong to garner awards at this year's TechConnect, the world’s largest multisector event for fostering translational innovations and technology commercialisation.
The TechConnect conference was held in Washington, D.C., from 19 to 21 June 2023. During the conference, PolyU’s delegation showcased various innovative projects and explored potential collaboration opportunities with technology partners. Read more.
PolyU award-winning innovations
Ammonia-powered fuel cell-based electric vehicle
Professor Eric Cheng Ka-wai
Director of Power Electronics Research Centre
Being the world's first ammonia-powered electric vehicle, the innovation adopted ammonia-to-wheel energy conversion, where liquid ammonia stored inside a cylinder is broken down into nitrogen and hydrogen by catalysts to generate electricity and achieve zero carbon emission. In this project, hydrogen is produced from ammonia on the vehicle for feeding fuel cells. A large hydrogen storage is not needed as the hydrogen is consumed immediately. There are no hazardous issues from the hydrogen. Hence, it is safer and can be managed more easily.
Biomimicking photocrosslinkable nanocomposite bone grafts
Dr Zhao Xin
Associate Professor, Department of Biomedical Engineering
The innovation mirrors the structure of natural bone. The bone grafts can load and release bioactive molecules and activate cell-signaling pathways to simultaneously promote osteogenesis and angiogenesis while providing optimal mechanical support to the injured area in order to expedite the bone healing process. The product can compete in the growing market and serve a huge number of patients who are receiving orthopedic surgeries.
You Might Also Like
PolyU honours exceptional research postgraduate alumni
In recognition of the remarkable achievements of its PhD/MPhil alumni, PolyU is proud to announce the Outstanding Research Postgraduate Alumni Award 2023 winners. Capitalising on their research strengths and visions, the awardees manifest their...
PolyU scholar garners World Physiotherapy International Service Award
Congratulations to PolyU scholar Professor Marco Pang, Director of the University Research Facility in Behavioral and Systems Neuroscience and Chair Professor of Neurorehabilitation of the Department of Rehabilitation Sciences, on being honoured...
PolyU research finds baicalein a promising glaucoma treatment
Glaucoma, an eye condition that can lead to loss of vision, is prevalent among older adults worldwide, affecting a population of 64.3 million in 2013, which is estimated to increase to 111.8 million in 2040. The eye disease has become a pronounced...